| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | LD6B6TT8Q5 |
| InChI Key | PFTAWBLQPZVEMU-ZFWWWQNUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H14O6 |
| Molecular Weight | 290.27 |
| AlogP | 1.55 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 110.38 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 2500-12800 | 25100 | - | - | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A1A subfamily
|
- | 23000-28000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension | 2 | D006973 | ClinicalTrials |
| Friedreich Ataxia | 2 | D005621 | ClinicalTrials |
| Prediabetic State | 1 | D011236 | ClinicalTrials |
| Muscular Dystrophy, Duchenne | 1 | D020388 | ClinicalTrials |
| Muscular Dystrophy, Duchenne | 1 | D020388 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 76125 |
| ChEMBL | CHEMBL129482 |
| FDA SRS | LD6B6TT8Q5 |
| KEGG | C09728 |
| SureChEMBL | SCHEMBL862089 |
| ZINC | ZINC000000119978 |